(R)-Oxiran-2-ylmethyl 3-nitrobenzenesulfonate, 95.0%, 25g

2-Methyl-1-[4-(trifluoromethyl)phenyl]propan-2-amine hydrochloride, 1g

2-(1H-Benzoimidazol-2-yl)-phenylamine, 98.0%, 5g

N,N,2,2-Tetramethyl-1,3-propanediamine>98.0%(GC)(T)25mL

(2-chlorophenyl)[3-(methoxymethoxy)phenyl]methanone, 95.0%, 10g

TERT-BUTYL 6-BROMO-2H-PYRIDO[3,2-B][1,4]OXAZINE-4(3H)-CARBOXYLATE, 95.0%, 1g

methyl 5-(2-fluorophenyl)isoxazole-3-carboxylate, 95.0%, 250mg

3-(3-Aminopropoxy)propan-1-ol, 97%, 5g

N-(1,1-dioxidotetrahydrothien-3-yl)ethane-1,2-diamine dihydrochloride, 95.0%, 1g

Combretastatin A4 Phosphate Disodium Salt>98.0%(HPLC)100mg

5-Nitroanthranilic acid, 98.0%, 25g

4-((3-chlorophenyl)sulfonamido)benzoic acid, 95.0%, 2.5g

Solvent red 49, 97%, 25g